Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells
REM Toes, EIH van der Voort… - The Journal of …, 1998 - journals.aai.org
Synthetic peptide-based vaccines have been shown to induce potent protective and
therapeutic T cell-mediated immunity in preclinical animal models and are now being …
therapeutic T cell-mediated immunity in preclinical animal models and are now being …
[引用][C] Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells
RE TOES - J. Immunol., 1998 - cir.nii.ac.jp
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is
avoided by peptide presentation on dendritic cells | CiNii Research CiNii 国立情報学研究所 …
avoided by peptide presentation on dendritic cells | CiNii Research CiNii 国立情報学研究所 …
Enhancement of Tumor Outgrowth Through CTL Tolerization After Peptide Vaccination Is Avoided by Peptide Presentation on Dendritic Cells
REM Toes, EIH van der Voort… - The Journal of …, 1998 - journals.aai.org
Synthetic peptide-based vaccines have been shown to induce potent protective and
therapeutic T cell-mediated immunity in preclinical animal models and are now being …
therapeutic T cell-mediated immunity in preclinical animal models and are now being …
[PDF][PDF] Enhancement of Tumor Outgrowth Through CTL Tolerization After Peptide Vaccination Is Avoided by Peptide Presentation on Dendritic Cells
REM Toes, EIH van der Voort, SP Schoenberger… - 1998 - researchgate.net
Synthetic peptide-based vaccines have been shown to induce potent protective and
therapeutic T cell-mediated immunity in preclinical animal models and are now being …
therapeutic T cell-mediated immunity in preclinical animal models and are now being …
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells.
RE Toes, EI van der Voort… - … (Baltimore, Md.: 1950 …, 1998 - europepmc.org
Synthetic peptide-based vaccines have been shown to induce potent protective and
therapeutic T cell-mediated immunity in preclinical animal models and are now being …
therapeutic T cell-mediated immunity in preclinical animal models and are now being …
Enhancement of tumor outgrowth through CTL tolerization after peptide vaccination is avoided by peptide presentation on dendritic cells
RE Toes, EI van der Voort… - Journal of …, 1998 - pubmed.ncbi.nlm.nih.gov
Synthetic peptide-based vaccines have been shown to induce potent protective and
therapeutic T cell-mediated immunity in preclinical animal models and are now being …
therapeutic T cell-mediated immunity in preclinical animal models and are now being …